Literature DB >> 16225475

Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.

V Ratziu1, A Heurtier, L Bonyhay, T Poynard, P Giral.   

Abstract

There is now consistent epidemiological evidence for an association between chronic hepatitis C and diabetes. Important, although so far limited longitudinal data, have documented an increased risk for diabetes in patients infected by hepatitis C virus (HCV) especially in those with metabolic risk factors such as a high BMI and older age. HCV encoded proteins might alter insulin signalling thus explaining impaired insulin sensitivity and the occurrence of glycaemic dysregulation even before the cirrhotic stage. The consequences of the association between diabetes and HCV infection are an increased liver fibrosis stage and faster fibrosis progression rate. This article reviews recent human and experimental data on the HCV-diabetes association.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225475     DOI: 10.1111/j.1365-2036.2005.02598.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

Review 1.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

Review 2.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.

Authors:  Silvia Fabiani; Poupak Fallahi; Silvia Martina Ferrari; Mario Miccoli; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

4.  Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.

Authors:  Miklos Z Molnar; Hazem M Alhourani; Barry M Wall; Jun L Lu; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

5.  Prevalence and factors affecting occurrence of type 2 diabetes mellitus in Saudi patients with chronic liver disease.

Authors:  Ashwani K Singal; Ayobanji E Ayoola
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

6.  Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.

Authors:  Amedeo Lonardo; Stefano Ballestri; Luigi E Adinolfi; Enrico Violi; Lucia Carulli; Silvia Lombardini; Federica Scaglioni; Matteo Ricchi; Giuseppe Ruggiero; Paola Loria
Journal:  Can J Gastroenterol       Date:  2009-04       Impact factor: 3.522

7.  Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.

Authors:  Jolanta Zuwala-Jagiello; Monika Pazgan-Simon; Eugenia Murawska-Cialowicz; Krzysztof Simon
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

8.  Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway.

Authors:  Qian Wang; Jizheng Chen; Yun Wang; Xiao Han; Xinwen Chen
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

9.  Peroxisome proliferator-activated receptors in HCV-related infection.

Authors:  Sébastien Dharancy; Maud Lemoine; Philippe Mathurin; Lawrence Serfaty; Laurent Dubuquoy
Journal:  PPAR Res       Date:  2009-03-30       Impact factor: 4.964

10.  A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections.

Authors:  Edward K Chow; Antonio Castrillo; Arash Shahangian; Liming Pei; Ryan M O'Connell; Robert L Modlin; Peter Tontonoz; Genhong Cheng
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.